等待开盘 10-06 09:30:00 美东时间
-0.246
-21.05%
Aldeyra Therapeutics stock surges as the company files an FDA dispute resolution for its dry eye drug reproxalap following a rejection.
09-30 02:34
US stocks started higher this morning, with NASDAQ up over 100 points. Energy shares rose by 1.3%, while Aldeyra and Meiwu Tech saw sharp declines.
03-17 22:19
FDA extends Aldeyra's reproxalap PDUFA date to March 2026 after a major NDA amendment tied to new clinical study report data.
2025-12-16 22:25